doi: 10.1053/AJKD034s00074.
V. Patient mortality and survival in ESRD
- PMID: 10431004
- DOI: 10.1053/AJKD034s00074
Item in Clipboard
V. Patient mortality and survival in ESRD
Am J Kidney Dis.
1999 Aug.
No abstract available
Similar articles
-
[REIN Report 2011--summary].Nephrol Ther. 2013 Sep;9 Suppl 1:S3-6. doi: 10.1016/S1769-7255(13)70036-1. Nephrol Ther. 2013. PMID: 24119584 French.
-
XII. International comparisons of ESRD therapy.Am J Kidney Dis. 1999 Aug;34(2 Suppl 1):S144-51. doi: 10.1053/AJKD034s00144. Am J Kidney Dis. 1999. PMID: 10431011 No abstract available.
-
Trends in end-stage renal disease. Epidemiology, morbidity, and mortality.Postgrad Med. 2000 Jul;108(1):124-6, 129-31, 135-6 passim. doi: 10.3810/pgm.2000.07.1152. Postgrad Med. 2000. PMID: 10914123 Review.
-
VIII. Pediatric end-stage renal disease.Am J Kidney Dis. 1999 Aug;34(2 Suppl 1):S102-13. doi: 10.1053/AJKD034s00102. Am J Kidney Dis. 1999. PMID: 10431007 No abstract available.
-
Optimizing end-stage renal disease therapy for the patient with diabetes mellitus.Semin Nephrol. 1997 Jul;17(4):331-45. Semin Nephrol. 1997. PMID: 9241718 Review.
Cited by
-
Coronary calcification in patients with chronic kidney disease and coronary artery disease.Clin J Am Soc Nephrol. 2009 Dec;4(12):1892-900. doi: 10.2215/CJN.04320709. Epub 2009 Oct 15. Clin J Am Soc Nephrol. 2009. PMID: 19833908 Free PMC article.
-
Risk factors for in-hospital mortality in patients starting hemodialysis.Kidney Res Clin Pract. 2015 Sep;34(3):154-9. doi: 10.1016/j.krcp.2015.07.005. Epub 2015 Aug 12. Kidney Res Clin Pract. 2015. PMID: 26484040 Free PMC article.
-
The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection.Clin Interv Aging. 2013;8:149-56. doi: 10.2147/CIA.S38349. Epub 2013 Feb 11. Clin Interv Aging. 2013. PMID: 23430986 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
